Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation – a secondary analysis of the PETN-pilot trial
Authors:
- 21 December 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 46 (9) , 1004-1009
Abstract
Aim: In pregnancies complicated by impaired utero-placental perfusion, pentaeritrithyltetranitrate (PETN) has been shown to reduce the risk of severe fetal growth restriction (FGR) and perinatal death by 39%. The effect is most likely related to the vasodilatative influence of PETN. To assess its impact on utero-placental and fetal perfusion, we analyzed the Doppler parameters measured during the PETN pilot-trial. Methods: One hundred and eleven pregnancies presenting impaired utero-placental resistance at mid-gestation were included in the trial. Fifty-four women received PETN, while 57 received a placebo. Doppler velocimetry measurements were monitored biweekly. Statistical analysis was performed using a mixed linear model. Results: Within the first week of treatment, the mean pulsatility index (PI) of the uterine artery (UtA) dropped more prominently in the PETN group [−0.20, 95% confidence interval (CI): −0.34 to −0.05, P=0.007). The adjusted relative risk (RR) for abnormal cerebro-placental ratio (CPR) was significantly reduced by PETN [RR 0.412 (95% CI: 0.181–0.941)]. Kaplan-Meier analysis demonstrates the postponement of absent end-diastolic flow (AED), absent or reverse end-diastolic flow (ARED), brain sparing and abnormal cerebroplacental ratio (CPR) in the PETN group. Conclusion: The demonstrated effect of PETN on utero-placental and feto-placental perfusion strengthens the evidence for a positive impact in pregnancies complicated by impaired placental perfusion and might explain the effect on neonatal outcome, as shown in the PETN-pilot trial.Keywords
This publication has 32 references indexed in Scilit:
- Maternal demographics and hemodynamics for the prediction of fetal growth restriction at booking, in pregnancies at high risk for placental insufficiencyActa Obstetricia et Gynecologica Scandinavica, 2016
- 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trialThe Lancet, 2015
- IFPA Gábor Than Award Lecture: Recognition of placental failure is key to saving babies' livesPlacenta, 2015
- Uterine and umbilical artery Doppler at 28 weeks for predicting adverse pregnancy outcomes in women with abnormal uterine artery Doppler findings in the early second trimesterPrenatal Diagnosis, 2015
- Unfractionated heparin and placental pathology in high-risk pregnancies: Secondary analysis of a pilot randomized controlled trialPlacenta, 2014
- Prediction and prevention of ischemic placental diseaseSeminars in Perinatology, 2014
- Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysisUltrasound in Obstetrics & Gynecology, 2013
- Effectiveness of interventions for the prevention of small‐for‐gestational age fetuses and perinatal mortality: a review of systematic reviewsActa Obstetricia et Gynecologica Scandinavica, 2012
- Intrauterine growth restriction: new standards for assessing adverse outcomeBest Practice & Research Clinical Obstetrics & Gynaecology, 2009
- Effect of In Utero and Early-Life Conditions on Adult Health and DiseaseNew England Journal of Medicine, 2008